Product Details

Diabetes

Glipita Tablet 50mg

Out of Stock

Call for price

<h2> </h2>15 tabletsGlipitaSitagliptinTabletDescriptionGilpitas an orally-active, potent and highly selective inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme for the treatment of type-It diabotes. The OPP.4) inhibitors are a class of agents that act as incretin enhancers. By inhibiting the DPP-4 enzyme, Sitagliptin increases the levels of two known active incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide(GIP)IndicationsIt is used in the treatment of type-11 diabetes mellitus, as mono-therapy or as dual therapy with Metformin, a sulfonylurea, of thiazolidinedione. Triple therapy using Sitagliptin with Metformin a sulfonylurea may be gives if dual therapy is inadequate.

SKU:
Category: Diabetes
Brand: Glipita-M

15 tablets

Glipita

Sitagliptin

Tablet

Description

Gilpitas an orally-active, potent and highly selective inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme for the treatment of type-It diabotes. The OPP.4) inhibitors are a class of agents that act as incretin enhancers. By inhibiting the DPP-4 enzyme, Sitagliptin increases the levels of two known active incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide

(GIP)

Indications

It is used in the treatment of type-11 diabetes mellitus, as mono-therapy or as dual therapy with Metformin, a sulfonylurea, of thiazolidinedione. Triple therapy using Sitagliptin with Metformin a sulfonylurea may be gives if dual therapy is inadequate.

No additional specifications available.

No vendor information available.